Roberto Rabello Filho

Dr. Roberto Rabello Filho


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
CPCarolina R. Ponzoni
Carolina R. Ponzoni
TCThiago D. Corrêa
Thiago D. Corrêa
RFRoberto Rabello Filho
Roberto Rabello Filho
ANAry Serpa Neto
Ary Serpa Neto
MAMurillo S. C. Assunção
Murillo S. C. Assunção
GSGuilherme P. P. Schettino
Guilherme P. P. Schettino
Rationale: Readmission to the intensive care unit (ICU) is associated with poor clinical outcomes, increased length of ICU and hospital stay, and higher costs. Nevertheless, knowledge of epidemiology of ICU readmissions, risk factors, and attributable outcomes is restricted to developed countries. Objectives: To determine the effect of ICU readmissions on in-hospital mortality, determine incidence of ICU readmissions, identify predictors of ICU readmissions and hospital mortality, and compare resource use and outcomes between readmitted and nonreadmitted patients in a developing country. Methods: This retrospective single-center cohort study was conducted in a 40-bed, open medical-surgical ICU of a private, tertiary care hospital in São Paulo, Brazil. The Local Ethics Committee at Hospital Israelita Albert Einstein approved the study protocol, and the need for informed consent was waived. All consecutive adult (≥18 yr) patients admitted to the ICU between June 1, 2013 and July 1, 2015 were enrolled in this study. Results: Comparisons were made between patients readmitted and not readmitted to the ICU. Logistic regression analyses were performed to identify predictors of ICU readmissions and hospital mortality. Out of 5,779 patients admitted to the ICU, 576 (10%) were readmitted to the ICU during the same hospitalization. Compared with nonreadmitted patients, patients readmitted to the ICU were more often men (349 of 576 patients [60.6%] vs. 2,919 of 5,203 patients [56.1%]; P = 0.042), showed a higher (median [interquartile range]) severity of illness (Simplified Acute Physiology III score) at index ICU admission (50 [41–61] vs. 42 [32–54], respectively, for readmitted and nonreadmitted patients; P < 0.001), and were more frequently admitted due to medical reasons (425 of 576 [73.8%] vs. 2,998 of 5,203 [57.6%], respectively, for readmitted and nonreadmitted patients; P < 0.001). Simplified Acute Physiology III score (P < 0.001), ICU admission from the ward (odds ratio [OR], 1.907; 95% confidence interval [CI], 1.463–2.487; P < 0.001), vasopressors need during index ICU stay (OR, 1.391; 95% CI, 1.130–1.713; P = 0.002), and length of ICU stay (P = 0.001) were independent predictors of ICU readmission. After adjusting for severity of illness, ICU readmission (OR, 4.103; 95% CI, 3.226–5.518; P < 0.001), admission source, presence of cancer, use of vasopressors, mechanical ventilation or renal replacement therapy, length of ICU stay, and nighttime ICU discharge were associated with increased risk of in-hospital death. Conclusions: Readmissions to the ICU were frequent and strongly related to poor outcomes. The degree to which ICU readmissions are preventable as well as the main causes of preventable ICU readmissions need to be further determined.

22 November 2021 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
TCThiago Domingos Corrêa
Thiago Domingos Corrêa
TMThais Dias Midega
Thais Dias Midega
KTKarina Tavares Timenetsky
Karina Tavares Timenetsky
RCRicardo Luiz Cordioli
Ricardo Luiz Cordioli
CBCarmen Silvia Valente Barbas
Carmen Silvia Valente Barbas
LFLeonardo José Rolim Ferraz
Leonardo José Rolim Ferraz
Objective: To describe clinical characteristics, resource use, outcomes, and to identify predictors of in-hospital mortality of patients with COVID-19 admitted to the intensive care unit. Methods: Retrospective single-center cohort study conducted at a private hospital in São Paulo (SP), Brazil. All consecutive adult (≥18 years) patients admitted to the intensive care unit, between March 4, 2020 and February 28, 2021 were included in this study. Patients were categorized between survivors and non-survivors according to hospital discharge. Results: During the [...] ABSTRACT Objective: To describe clinical characteristics, resource use, outcomes, and to identify predictors of in-hospital mortality of patients with COVID-19 admitted to the intensive care unit. Methods: Retrospective single-center cohort study conducted at a private hospital in São Paulo (SP), Brazil. All consecutive adult (≥18 years) patients admitted to the intensive care unit, between March 4, 2020 and February 28, 2021 were included in this study. Patients were categorized between survivors and non-survivors according to hospital discharge. Results: During the

21 November 2019 in Journal of Clinical Monitoring and Computing
Verified
Journal Article
Open access
PDF file
RFRoberto Rabello Filho
Roberto Rabello Filho
RCRenato Carneiro de Freitas Chaves
Renato Carneiro de Freitas Chaves
MAMurillo Santucci Cesar Assunção
Murillo Santucci Cesar Assunção
ANAry Serpa Neto
Ary Serpa Neto
FFFlavia Manfredi De Freitas
Flavia Manfredi De Freitas
TCThiago Domingos Corrêa
Thiago Domingos Corrêa
Microvascular dysfunction has been associated with adverse outcomes in critically ill patients, and the current concept of hemodynamic incoherence has gained attention. Our objective was to perform a comprehensive analysis of microcirculatory perfusion parameters and to investigate the best variables that could discriminate patients with and without circulatory shock during early intensive care unit (ICU) admission. This prospective observational study comprised a sample of 40 adult patients with and without circulatory shock (n = 20, each) admitted to the ICU within 24 h. Peripheral clinical [capillary refill time (CRT), peripheral perfusion index (PPI), skin-temperature gradient (Tskin-diff)] and laboratory [arterial lactate and base excess (BE)] perfusion parameters, in addition to near-infrared spectroscopy (NIRS)-derived variables were simultaneously assessed. While lactate, BE, CRT, PPI and Tskin-diff did not differ significantly between the groups, shock patients had lower baseline tissue oxygen saturation (StO2) [81 (76–83) % vs. 86 (76–90) %, p = 0.044], lower StO2min [50 (47–57) % vs. 55 (53–65) %, p = 0.038] and lower StO2max [87 (80–92) % vs. 93 (90–95) %, p = 0.017] than patients without shock. Additionally, dynamic NIRS variables [recovery time (r = 0.56, p = 0.010), descending slope (r = − 0.44, p = 0.05) and ascending slope (r = − 0.54, p = 0.014)] and not static variable [baseline StO2 (r = − 0.24, p = 0.28)] exhibited a significant correlation with the administered dose of norepinephrine. In our study with critically ill patients assessed within the first twenty-four hours of ICU admission, among the perfusion parameters, only NIRS-derived parameters could discriminate patients with and without shock.

12 March 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
FCFabrício Rodrigues Torres de Carvalho
Fabrício Rodrigues Torres de Carvalho
JTJoao Paulo Telles
Joao Paulo Telles
FTFelipe Francisco Tuon
Felipe Francisco Tuon
RFRoberto Rabello Filho
Roberto Rabello Filho
PCPedro Caruso
Pedro Caruso
TCThiago Domingos Correa
Thiago Domingos Correa
Antibiotics misuse and overuse are concerning issues worldwide, especially in low middle-income countries. These practices contribute to the increasing rates of antimicrobial resistance. One efficient strategy to avoid them is antimicrobial stewardship programs. In this review, we focus on the possible approaches to spare the prescription of polymyxins and carbapenems for the treatment of Acinetobacter baumannii, carbapenem-resistant Enterobacterales, and Pseudomonas aeruginosas infections. Additionally, we highlight how to implement cumulative antibiograms and biomarkers to a sooner de-escalation of antibiotics.

29 May 2020 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
TCThiago Domingos Corrêa
Thiago Domingos Corrêa
GMGustavo Faissol Janot de Matos
Gustavo Faissol Janot de Matos
BBBruno de Arruda Bravim
Bruno de Arruda Bravim
RCRicardo Luiz Cordioli
Ricardo Luiz Cordioli
AGAlejandra del Pilar Gallardo Garrido
Alejandra del Pilar Gallardo Garrido
LFLeonardo José Rolim Ferraz
Leonardo José Rolim Ferraz
In December 2019, a series of patients with severe pneumonia were identified in Wuhan, Hubei province, China, who progressed to severe acute respiratory syndrome and acute respiratory distress syndrome. Subsequently, COVID-19 was attributed to a new betacoronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Approximately 20% of patients diagnosed as COVID-19 develop severe forms of the disease, including acute hypoxemic respiratory failure, severe acute respiratory syndrome, acute respiratory distress syndrome and acute renal failure and require intensive care. There is no randomized controlled clinical trial addressing potential therapies for patients with confirmed COVID-19 infection at the time of publishing these treatment recommendations. Therefore, these recommendations are based predominantly on the opinion of experts (level C of recommendation).

31 July 2020 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
TCThiago Domingos Corrêa
Thiago Domingos Corrêa
GMGustavo Faissol Janot de Matos
Gustavo Faissol Janot de Matos
BBBruno de Arruda Bravim
Bruno de Arruda Bravim
RCRicardo Luiz Cordioli
Ricardo Luiz Cordioli
AGAlejandra del Pilar Gallardo Garrido
Alejandra del Pilar Gallardo Garrido
LFLeonardo José Rolim Ferraz
Leonardo José Rolim Ferraz
Dear Editor, In this issue of einstein journal (São Paulo), Corrêa et al., reported intensive support recommendations for critically-ill patients with suspected or confirmed infection by the new coronavirus (COVID-19).() Based on preliminary demonstration of efficacy of chloroquine, the authors suggested the use of hydroxychloroquine in monotherapy or combined with a macrolide (azithromycin or clarithromycin), to treat severe patients with COVID-19, admitted to the intensive care unit (ICU), to inhibit in vitro replication of severe acute respiratory syndrome coronavirus 2 [...] Dear Editor, In this issue of einstein journal (São Paulo), Corrêa et al., reported intensive support recommendations for critically-ill patients with suspected or confirmed infection by the new coronavirus (COVID-19).() Based on preliminary demonstration of efficacy of chloroquine, the authors suggested the use of hydroxychloroquine in monotherapy or combined with a macrolide (azithromycin or clarithromycin), to treat severe patients with COVID-19, admitted to the intensive care unit (ICU), to inhibit in vitro replication of severe acute respiratory syndrome coronavirus 2